Findings could be good news for wheat farmers

Scientists have announced a breakthrough in work to protect wheat against disease. Disease cost farmers worldwide millions of pounds in lost and damaged crops but work carried out in the UK promises to improve testing...

Newcastle based company addresses key challenge to the success of lab-grown meat

With a predicted world population reaching just short of 10 billion by 2050 (3 billion more than there were in 2010), developing efficient, environmentally friendly and affordable food production technologies becomes a real challenge....

Blood cancer’s Achilles’ heel

New findings about a fatal form of blood cancer could aid the development of new drugs with significantly less harmful side effects than existing chemotherapy. The discovery could lead to novel treatments that efficiently eliminate...

UK offers accelerated patent protection for eco-friendly innovations

Using the Green Channel to accelerate a UK patent application. AdamsonJones was able to obtain patent protection for client, LLEO Ltd, in just 15 months from the moment the Green Channel was used. This acceleration was crucial as...

Activity the key to optimising stroke recovery

Emphasising the importance of sustained rehabilitation can help health services cope with rising numbers of people surviving a stroke, a University of Dundee expert has said. Dr Jacqui Morris, Reader in Rehabilitation Research at the...

Eligible costs for R&D Tax Relief – it’s not just for those people in...

For my fellow professionals who work with businesses to support them with claims for Research and Development Tax Relief, one of our common mantras when explaining to manufacturing businesses, engineering firms and software developers...

Ultra Scale-Down – Is this the answer to accelerated access of new medicines?

Afrin Zohura, USD Bioprocess Research Engineer, University College London (UCL) How to develop new drugs, therapies and technologies in a timely manner is one of the most pressing concerns of our time. Recently, UK Business...

Possible impact of no-deal Brexit on EU IP rights

How would a no-deal Brexit affect the protection of EU intellectual property rights in the UK? The UK government issued guidance on 24 September 2018 confirming that EU trade mark and design rights will continue...

Gene editing research bid overcomes crucial hurdle

The UK is leading the world after the national Human Fertilisation and Embryology Authority (HFEA) approved a research application from the Francis Crick Institute to use new gene editing techniques on human embryos. decision after...

Epilepsy work could throw light on the human condition

New research from the Royal Veterinary College canine epilepsy clinic has provided information on why some dogs do not respond to anti-epilepsy treatments.  The work could shed light on the condition in humans due to...

Hope for sufferers

Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be a treatment for neurodegenerative diseases. Neurodegeneration, which involves the progressive loss of nerve structure and function, is a common...

Project to predict cardiovascular events receives Heart Research UK grant

A project at the University of Manchester aiming to develop a new tool for predicting the risk of a cardiovascular event or death in patients who have already suffered a heart attack has received...

Servier launches InnoPreP™, its new preparative chromatography offer

Servier, an independent international pharmaceutical company, has announced the launch of InnoPreP™ – a new preparative chromatography service offered under its contract development and manufacturing business. Servier has employed preparative chromatography for over 30 years...

The Northern biomedical sector celebrated at prestigious awards ceremony

The best of the North of England’s biomedical companies were honoured at the 2014 Biomedical Awards, hosted by Bionow at the BALTIC Centre for Contemporary Art, on Gateshead Quays on 24 April 2014. Sixteen companies battled...

Research centres are confirmed

Two Cambridge institutes have been confirmed as major research centres by biomedical research charity Wellcome. The Wellcome/CRUK Gurdon Institute and Wellcome/MRC Cambridge Stem Cell Institute have been named as two of 14 Wellcome Centres which...

Team targets personalised cancer treatment

A new personalised breast cancer programme has been launched to map patients’ DNA and RNA to tailor treatment. The Cancer Research UK project, which was launched with £1.1 million from Addenbrooke’s Charitable Trust, (ACT), will...